IBEX 3518.989,80▲ +0,40%EuroStoxx 506068,22▼ -0,31%S&P 5007628,51▼ -0,46%€/$1,1197▼ -0,22%Brent111,53▲ +2,64%Bitcoin72.687▲ +0,30%

Breaking

Telemadrid admits it cannot pay the 60 million demanded by the Tax AgencyGemini adds a business page for SMEs, with no confirmed date in SpainKisqali Reduces Risk of Death by 19.1% in Early Breast CancerThe National Court halts Repsol's payment of 120.3 millionCaixaBank named best bank for SMEs in Spain and Western EuropeDebt and Housing: What Feijóo Says Against Official Data

ESMO

Latest ESMO news

1 article

Illustrative image: a laboratory glass vial on a wooden table at sunset, with long shadows.

Companies

Kisqali Reduces Risk of Death by 19.1% in Early Breast Cancer

Kisqali from Novartis reduces the risk of death by 19.1% in high-risk early HR+/HER2- breast cancer compared to endocrine therapy alone, according to the NATALEE trial.

Beatriz Lorenzo Aguirre · 23 October 2026